Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED Sodium Citrate and Citric Acid Oral Solution USP (colorless, cherry flavor) is supplied in the following oral dosage forms: NDC 50268-182-11: 15 mL unit dose cup NDC 50268-182-15: Case contains 40 unit dose cups of 15 mL NDC 50268-183-11: 30 mL unit dose cup NDC 50268-183-30: Case contains 40 unit dose cups of 30 mL; PRINCIPAL DISPLAY PANEL - 15 mL Unit Dose Cup Label 15; PRINCIPAL DISPLAY PANEL - 30 mL Unit Dose Cup Label 30
- HOW SUPPLIED Sodium Citrate and Citric Acid Oral Solution USP (colorless, cherry flavor) is supplied in the following oral dosage forms: NDC 50268-182-11: 15 mL unit dose cup NDC 50268-182-15: Case contains 40 unit dose cups of 15 mL NDC 50268-183-11: 30 mL unit dose cup NDC 50268-183-30: Case contains 40 unit dose cups of 30 mL
- PRINCIPAL DISPLAY PANEL - 15 mL Unit Dose Cup Label 15
- PRINCIPAL DISPLAY PANEL - 30 mL Unit Dose Cup Label 30
Overview
Sodium Citrate and Citric Acid Oral Solution USP is a stable and pleasant-tasting systemic alkalizer containing sodium citrate and citric acid in a sugar-free base. It is a nonparticulate neutralizing buffer. Sodium Citrate and Citric Acid Oral Solution USP contains in each teaspoonful (5 mL): SODIUM CITRATE Dihydrate 500 mg (0.34 Molar) CITRIC ACID Monohydrate 334 mg (0.32 Molar) Each mL contains 1 mEq sodium ion and is equivalent to 1 mEq bicarbonate (HCO3). INACTIVE INGREDIENTS: Flavoring, purified water, sodium benzoate, and sucralose solution.
Indications & Usage
Sodium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent. It is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. This product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. Sodium Citrate and Citric Acid Oral Solution USP is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. This product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods.
Dosage & Administration
Sodium Citrate and Citric Acid Oral Solution USP should be taken diluted in water, followed by additional water, if desired. SHAKE WELL BEFORE USING.
Warnings & Precautions
No warnings available yet.
Contraindications
Patients on sodium-restricted diets or with severe renal impairment.
Adverse Reactions
Sodium Citrate and Citric Acid Oral Solution USP is generally well tolerated, without any unpleasant side effects, when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of alkalosis, especially in the presence of hypocalcemia. To report SUSPECTED ADVERSE REACTIONS, contact AvKARE at 1-800-361-3993 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch..
Storage & Handling
STORAGE: Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). Protect from freezing.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.